Thailand’s Bioscience Animal Health (BIS), an animal drug and vaccine provider, reported a revenue of USD 14.1 million in Q2 2022, up 2% yoy. Revenue from its diagnostic products division increased 5% on higher demand for ASF test kits and higher sales from pet diagnostic products. Revenue from fee...
Sign in as a member, or Join our Community for free to unlock the full article.
Thailand’s Bioscience Animal Health (BIS), an animal drug and vaccine provider, reported a revenue of USD 14.1 million in Q2 2022, up 2% yoy. Revenue from its diagnostic products division increased 5% on higher demand for ASF test kits and higher sales from pet diagnostic products. Revenue from fee...
Sign in as a member, or Join our Community for free to unlock the full article.
Thailand’s Bioscience Animal Health (BIS), an animal drug and vaccine provider, reported a revenue of USD 14.1 million in Q2 2022, up 2% yoy. Revenue from its diagnostic products division increased 5% on higher demand for ASF test kits and higher sales from pet diagnostic products. Revenue from fee...
Sign in as a member, or Join our Community for free to unlock the full article.
Thailand’s Bioscience Animal Health (BIS), an animal drug and vaccine provider, reported a revenue of USD 14.1 million in Q2 2022, up 2% yoy. Revenue from its diagnostic products division increased 5% on higher demand for ASF test kits and higher sales from pet diagnostic products. Revenue from fee...
Sign in as a member, or Join our Community for free to unlock the full article.
Thailand’s Bioscience Animal Health (BIS), an animal drug and vaccine provider, reported a revenue of USD 14.1 million in Q2 2022, up 2% yoy. Revenue from its diagnostic products division increased 5% on higher demand for ASF test kits and higher sales from pet diagnostic products. Revenue from fee...
Sign in as a member, or Join our Community for free to unlock the full article.
Thailand’s Bioscience Animal Health (BIS), an animal drug and vaccine provider, reported a revenue of USD 14.1 million in Q2 2022, up 2% yoy. Revenue from its diagnostic products division increased 5% on higher demand for ASF test kits and higher sales from pet diagnostic products. Revenue from fee...
Sign in as a member, or Join our Community for free to unlock the full article.
Thailand’s Bioscience Animal Health (BIS), an animal drug and vaccine provider, reported a revenue of USD 14.1 million in Q2 2022, up 2% yoy. Revenue from its diagnostic products division increased 5% on higher demand for ASF test kits and higher sales from pet diagnostic products. Revenue from fee...
Sign in as a member, or Join our Community for free to unlock the full article.
Thailand’s Bioscience Animal Health (BIS), an animal drug and vaccine provider, reported a revenue of USD 14.1 million in Q2 2022, up 2% yoy. Revenue from its diagnostic products division increased 5% on higher demand for ASF test kits and higher sales from pet diagnostic products. Revenue from fee...
Sign in as a member, or Join our Community for free to unlock the full article.
Thailand’s Bioscience Animal Health (BIS), an animal drug and vaccine provider, reported a revenue of USD 14.1 million in Q2 2022, up 2% yoy. Revenue from its diagnostic products division increased 5% on higher demand for ASF test kits and higher sales from pet diagnostic products. Revenue from fee...
Sign in as a member, or Join our Community for free to unlock the full article.
Thailand’s Bioscience Animal Health (BIS), an animal drug and vaccine provider, reported a revenue of USD 14.1 million in Q2 2022, up 2% yoy. Revenue from its diagnostic products division increased 5% on higher demand for ASF test kits and higher sales from pet diagnostic products. Revenue from fee...
Sign in as a member, or Join our Community for free to unlock the full article.
Thailand’s Bioscience Animal Health (BIS), an animal drug and vaccine provider, reported a revenue of USD 14.1 million in Q2 2022, up 2% yoy. Revenue from its diagnostic products division increased 5% on higher demand for ASF test kits and higher sales from pet diagnostic products. Revenue from fee...
Sign in as a member, or Join our Community for free to unlock the full article.
Thailand’s Bioscience Animal Health (BIS), an animal drug and vaccine provider, reported a revenue of USD 14.1 million in Q2 2022, up 2% yoy. Revenue from its diagnostic products division increased 5% on higher demand for ASF test kits and higher sales from pet diagnostic products. Revenue from fee...
Sign in as a member, or Join our Community for free to unlock the full article.
Thailand’s Bioscience Animal Health (BIS), an animal drug and vaccine provider, reported a revenue of USD 14.1 million in Q2 2022, up 2% yoy. Revenue from its diagnostic products division increased 5% on higher demand for ASF test kits and higher sales from pet diagnostic products. Revenue from fee...
Sign in as a member, or Join our Community for free to unlock the full article.
Thailand’s Bioscience Animal Health (BIS), an animal drug and vaccine provider, reported a revenue of USD 14.1 million in Q2 2022, up 2% yoy. Revenue from its diagnostic products division increased 5% on higher demand for ASF test kits and higher sales from pet diagnostic products. Revenue from fee...
Sign in as a member, or Join our Community for free to unlock the full article.
Thailand’s Bioscience Animal Health (BIS), an animal drug and vaccine provider, reported a revenue of USD 14.1 million in Q2 2022, up 2% yoy. Revenue from its diagnostic products division increased 5% on higher demand for ASF test kits and higher sales from pet diagnostic products. Revenue from fee...
Sign in as a member, or Join our Community for free to unlock the full article.
Thailand’s Bioscience Animal Health (BIS), an animal drug and vaccine provider, reported a revenue of USD 14.1 million in Q2 2022, up 2% yoy. Revenue from its diagnostic products division increased 5% on higher demand for ASF test kits and higher sales from pet diagnostic products. Revenue from fee...
Sign in as a member, or Join our Community for free to unlock the full article.
Thailand’s Bioscience Animal Health (BIS), an animal drug and vaccine provider, reported a revenue of USD 14.1 million in Q2 2022, up 2% yoy. Revenue from its diagnostic products division increased 5% on higher demand for ASF test kits and higher sales from pet diagnostic products. Revenue from fee...
Sign in as a member, or Join our Community for free to unlock the full article.
ASIAN AGRIBUSINESS MEDIA PTE LTD
Would you like to join your colleagues in the Asian Agribiz Community. Click here to JOIN NOW!
